These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
273 related items for PubMed ID: 4185738
1. [Present status of the prevention of hemolytic disease of the newborn due to Rh factors incompatibility]. de Sousa JS. Rev Port Pediatr Pueric; 1969; 32(3):70-6. PubMed ID: 4185738 [No Abstract] [Full Text] [Related]
2. [Rhesus sensitization and prevention with anti-D-immunoglobulin]. Hindemann P, Hinselmann M, Frey P. Gynaecologia; 1969; 167(5):276-9. PubMed ID: 4184763 [No Abstract] [Full Text] [Related]
3. [Prevention of hemolytic disease of the newborn using anti-rhesus (D) gamma globulin]. Borst-Eilers E. Maandschr Kindergeneeskd; 1969 Dec; 37(7):243-51. PubMed ID: 4188422 [No Abstract] [Full Text] [Related]
6. [Current data and contribution to the study of hemolytic disease caused by feto-maternal blood incompatibility]. Trifan N, Lupaşcu G, Trifan E. Rev Med Chir Soc Med Nat Iasi; 1971 Apr; 75(4):1049-54. PubMed ID: 4135203 [No Abstract] [Full Text] [Related]
7. Prevention of Rh haemolytic disease. Clarke CA. Nurs Mirror Midwives J; 1974 Oct 24; 139(17):57-9. PubMed ID: 4139694 [No Abstract] [Full Text] [Related]
8. [Prevention of anti Rh immunization]. Pinon F. Sem Hop; 1969 Sep 10; 45(37):2328-33. PubMed ID: 4187740 [No Abstract] [Full Text] [Related]
9. [Immunohematology of hemolytic disease of the newborn]. Hrubisko M. Cesk Gynekol; 1969 Oct 10; 34(8):465-9. PubMed ID: 4187682 [No Abstract] [Full Text] [Related]
10. Current clinical concepts in hemolytic disease and blood group incompatibility. Cherry SH. Prog Clin Biol Res; 1981 Oct 10; 70():205-12. PubMed ID: 6273933 [No Abstract] [Full Text] [Related]
11. [Practical questions in the immunological prevention of Rh sensitization]. Althoff W, Schellong G, Stahl M. Munch Med Wochenschr; 1969 Jun 20; 111(25):1386-95. PubMed ID: 4185511 [No Abstract] [Full Text] [Related]
12. [Status of Rh sensitization prevention in the Federal Republic of Germany]. Stolp W, Schlenter W, Schneider J. Geburtshilfe Frauenheilkd; 1972 Sep 20; 32(9):762-72. PubMed ID: 4116752 [No Abstract] [Full Text] [Related]
13. Rh immunoglobulin in prevention of hemolytic disease of newborn child. Gorman JG. N Y State J Med; 1968 May 15; 68(10):1270-7. PubMed ID: 4172073 [No Abstract] [Full Text] [Related]
14. [Our experiences in the prevention of Rh sensitization]. Mikulandra F, Kapitanović IM. Bilt Hematol Transfuz; 1975 May 15; 3(3):65-8. PubMed ID: 57776 [No Abstract] [Full Text] [Related]
16. [Remote after-effects of hemolytic diseases in newborn, caused by the ABO- and Rh-incompatibility in the blood of mother and fetus]. Nersisian VM. Zh Eksp Klin Med; 1969 Apr 15; 9(5):82-5. PubMed ID: 4988140 [No Abstract] [Full Text] [Related]
17. [Hemolytic disease of the newborn caused by fetomaternal incompatibility]. Escandé CA, Lorenzo y de Ibarreta J, Temesio N, Garófalo O, Pérez-Scremini A, Vila-Vidal P, Vilanova R. Arch Pediatr Urug; 1965 Jul 15; 36(7):455-68. PubMed ID: 4954973 [No Abstract] [Full Text] [Related]
18. [Status of the prevention of the hemolytic disease of the newborn with gamma globulin in Switzerland]. de Muralt G, Stampfli K. Gynaecologia; 1969 Jul 15; 167(5):285-8. PubMed ID: 4184765 [No Abstract] [Full Text] [Related]
19. [Prevention of hemolytic disease in newborn infants]. Schneider J. Med Klin; 1969 Mar 28; 64(13):578-80. PubMed ID: 4182137 [No Abstract] [Full Text] [Related]
20. [Prevention of hemolytic disease of the newborn by use of anti-rhesus (D) immunoglobulin]. Borst-Eilers E. Ned Tijdschr Verloskd Gynaecol; 1969 Oct 28; 69(5):383-91. PubMed ID: 4186579 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]